QQQ   349.98 (+0.45%)
AAPL   177.30 (+1.07%)
MSFT   331.21 (-0.50%)
META   262.52 (+0.18%)
GOOGL   123.67 (-0.75%)
AMZN   121.66 (+1.29%)
TSLA   201.16 (+4.14%)
NVDA   401.11 (+2.99%)
NIO   7.41 (-3.77%)
BABA   78.67 (-2.84%)
AMD   125.27 (-1.39%)
T   15.64 (+0.90%)
F   12.59 (+4.14%)
MU   71.69 (-3.03%)
CGC   0.85 (-3.08%)
GE   102.40 (-0.33%)
DIS   87.82 (-0.53%)
AMC   4.63 (-0.22%)
PFE   37.01 (-1.57%)
PYPL   62.05 (+3.04%)
NFLX   392.98 (+3.72%)
QQQ   349.98 (+0.45%)
AAPL   177.30 (+1.07%)
MSFT   331.21 (-0.50%)
META   262.52 (+0.18%)
GOOGL   123.67 (-0.75%)
AMZN   121.66 (+1.29%)
TSLA   201.16 (+4.14%)
NVDA   401.11 (+2.99%)
NIO   7.41 (-3.77%)
BABA   78.67 (-2.84%)
AMD   125.27 (-1.39%)
T   15.64 (+0.90%)
F   12.59 (+4.14%)
MU   71.69 (-3.03%)
CGC   0.85 (-3.08%)
GE   102.40 (-0.33%)
DIS   87.82 (-0.53%)
AMC   4.63 (-0.22%)
PFE   37.01 (-1.57%)
PYPL   62.05 (+3.04%)
NFLX   392.98 (+3.72%)
QQQ   349.98 (+0.45%)
AAPL   177.30 (+1.07%)
MSFT   331.21 (-0.50%)
META   262.52 (+0.18%)
GOOGL   123.67 (-0.75%)
AMZN   121.66 (+1.29%)
TSLA   201.16 (+4.14%)
NVDA   401.11 (+2.99%)
NIO   7.41 (-3.77%)
BABA   78.67 (-2.84%)
AMD   125.27 (-1.39%)
T   15.64 (+0.90%)
F   12.59 (+4.14%)
MU   71.69 (-3.03%)
CGC   0.85 (-3.08%)
GE   102.40 (-0.33%)
DIS   87.82 (-0.53%)
AMC   4.63 (-0.22%)
PFE   37.01 (-1.57%)
PYPL   62.05 (+3.04%)
NFLX   392.98 (+3.72%)
QQQ   349.98 (+0.45%)
AAPL   177.30 (+1.07%)
MSFT   331.21 (-0.50%)
META   262.52 (+0.18%)
GOOGL   123.67 (-0.75%)
AMZN   121.66 (+1.29%)
TSLA   201.16 (+4.14%)
NVDA   401.11 (+2.99%)
NIO   7.41 (-3.77%)
BABA   78.67 (-2.84%)
AMD   125.27 (-1.39%)
T   15.64 (+0.90%)
F   12.59 (+4.14%)
MU   71.69 (-3.03%)
CGC   0.85 (-3.08%)
GE   102.40 (-0.33%)
DIS   87.82 (-0.53%)
AMC   4.63 (-0.22%)
PFE   37.01 (-1.57%)
PYPL   62.05 (+3.04%)
NFLX   392.98 (+3.72%)

Aquestive Therapeutics (AQST) Stock Reddit Activity & Social Media Sentiment

$2.06
-0.18 (-8.04%)
(As of 04:32 PM ET)
Compare
Today's Range
$1.99
$2.22
50-Day Range
$0.81
$2.49
52-Week Range
$0.62
$2.69
Volume
869,153 shs
Average Volume
439,310 shs
Market Capitalization
$115.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.13

Reddit Posts Over Time

Media Mentions Over Time



View Trending Media Stocks

MarketBeat New Follows Over Time



View Trending Stocks on MarketBeat

MarketBeat Searches Over Time



Recieve AQST News and Ratings via Email

Sign-up to receive the latest news and ratings for Aquestive Therapeutics and its competitors with MarketBeat's FREE daily newsletter.


AQST Social Media Mentions

Recent AQST Stock Reddit Threads

March 31st, 2023  2:25 PM  |  alexl_4 |  RobinHoodPennyStocks
$AQST - Long-term high-risk, high-reward, pharma play w/ potential for +1000% return

$AQST - Aquestive Therapeutics is a biotech company developing orally administered products to treat seizures, allergic reactions, and other CNS conditions. Enter Aquestives Lead Drug, AQST-109... Now for the real potential golden egg. Aquestive is working on an …

March 31st, 2023  2:02 PM  |  alexl_4 |  pennystocks
$AQST - Long-term high-risk, high-reward, pharma play w/ potential for +1000% return

$AQST - Aquestive Therapeutics is a biotech company developing orally administered products to treat seizures, allergic reactions, and other CNS conditions. Enter Aquestives Lead Drug, AQST-109... Now for the real potential golden egg. Aquestive is working on an …

March 30th, 2023  2:59 PM  |  alexl_4 |  investing
AQST Huge Potential Keeps going Up

$AQST - Long-term high-risk, high-reward, pharma play w/ potential for +1000% return Enter Aquestives Lead Drug, AQST-109...* Now for the real potential golden egg. Aquestive is working on an orally administered drug to treat allergies that is a direct alternative …

March 30th, 2023  2:30 PM  |  alexl_4 |  pennystocks
AQST Huge Potential

$AQST - Long-term high-risk, high-reward, pharma play w/ potential for +1000% return Enter Aquestives Lead Drug, AQST-109...* Now for the real potential golden egg. Aquestive is working on an orally administered drug to treat allergies that is a direct alternative …

March 29th, 2023  12:44 PM  |  alexl_4 |  stocks
AQST Huge Potential. Mods if you delete this you’re missing a chance of a lifetime

$AQST - Long-term high-risk, high-reward, pharma play w/ potential for +1000% return Enter Aquestives Lead Drug, AQST-109...* Now for the real potential golden egg. Aquestive is working on an orally administered drug to treat allergies that is a direct alternative …

March 29th, 2023  12:36 PM  |  alexl_4 |  investing_discussion
AQST huge potential

$AQST - Long-term high-risk, high-reward, pharma play w/ potential for +1000% return Enter Aquestives Lead Drug, AQST-109...* Now for the real potential golden egg. Aquestive is working on an orally administered drug to treat allergies that is a direct alternative …

March 29th, 2023  12:35 PM  |  alexl_4 |  investing
AQST Huge Potential. Nobody knows

$AQST - Long-term high-risk, high-reward, pharma play w/ potential for +1000% return Enter Aquestives Lead Drug, AQST-109...* Now for the real potential golden egg. Aquestive is working on an orally administered drug to treat allergies that is a direct alternative …

March 29th, 2023  12:34 PM  |  alexl_4 |  StockMarket
AQST Huge Potential

$AQST - Long-term high-risk, high-reward, pharma play w/ potential for +1000% return Enter Aquestives Lead Drug, AQST-109...* Now for the real potential golden egg. Aquestive is working on an orally administered drug to treat allergies that is a direct alternative …

March 29th, 2023  12:29 PM  |  alexl_4 |  pennystocks
AQST Huge Potential

$AQST - Long-term high-risk, high-reward, pharma play w/ potential for +1000% return Enter Aquestives Lead Drug, AQST-109...* Now for the real potential golden egg. Aquestive is working on an orally administered drug to treat allergies that is a direct alternative …

March 28th, 2023  4:18 PM  |  alexl_4 |  stocks
AQST stock that has huge potential

$AQST Aquestive Therapeutics  ($0.90) The Company is developing orally administered products to deliver molecules, providing alternatives to care therapies. It is engaged in advancing a late-stage product pipeline focused on treating diseases of the central nervous …


Related Companies and Tools

This page (NASDAQ:AQST) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -